Literature DB >> 18305103

Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.

Barbara Belletti1, Milena S Nicoloso, Monica Schiappacassi, Stefania Berton, Francesca Lovat, Katarina Wolf, Vincenzo Canzonieri, Sara D'Andrea, Antonella Zucchetto, Peter Friedl, Alfonso Colombatti, Gustavo Baldassarre.   

Abstract

The balanced activity of microtubule-stabilizing and -destabilizing proteins determines the extent of microtubule dynamics, which is implicated in many cellular processes, including adhesion, migration, and morphology. Among the destabilizing proteins, stathmin is overexpressed in different human malignancies and has been recently linked to the regulation of cell motility. The observation that stathmin was overexpressed in human recurrent and metastatic sarcomas prompted us to investigate stathmin contribution to tumor local invasiveness and distant dissemination. We found that stathmin stimulated cell motility in and through the extracellular matrix (ECM) in vitro and increased the metastatic potential of sarcoma cells in vivo. On contact with the ECM, stathmin was negatively regulated by phosphorylation. Accordingly, a less phosphorylable stathmin point mutant impaired ECM-induced microtubule stabilization and conferred a higher invasive potential, inducing a rounded cell shape coupled with amoeboid-like motility in three-dimensional matrices. Our results indicate that stathmin plays a significant role in tumor metastasis formation, a finding that could lead to exploitation of stathmin as a target of new antimetastatic drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305103      PMCID: PMC2366875          DOI: 10.1091/mbc.e07-09-0894

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  38 in total

Review 1.  How do microtubules guide migrating cells?

Authors:  J Victor Small; Benjamin Geiger; Irina Kaverina; Alexander Bershadsky
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

Review 2.  The tubulin code.

Authors:  Kristen J Verhey; Jacek Gaertig
Journal:  Cell Cycle       Date:  2007-06-26       Impact factor: 4.534

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer.

Authors:  D K Price; J R Ball; Z Bahrani-Mostafavi; J C Vachris; J S Kaufman; R W Naumann; R V Higgins; J B Hall
Journal:  Cancer Invest       Date:  2000       Impact factor: 2.176

5.  Drosophila stathmin: a microtubule-destabilizing factor involved in nervous system formation.

Authors:  Sylvie Ozon; Antoine Guichet; Olivier Gavet; Siegfried Roth; André Sobel
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

6.  Transforming properties of a Q18-->E mutation of the microtubule regulator Op18.

Authors:  David E Misek; Christina L Chang; Rork Kuick; Robert Hinderer; Thomas J Giordano; David G Beer; Samir M Hanash
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

Review 7.  Tumour-cell invasion and migration: diversity and escape mechanisms.

Authors:  Peter Friedl; Katarina Wolf
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

8.  The catastrophe-promoting activity of ectopic Op18/stathmin is required for disruption of mitotic spindles but not interphase microtubules.

Authors:  P Holmfeldt; N Larsson; B Segerman; B Howell; J Morabito; L Cassimeris; M Gullberg
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

9.  Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.

Authors:  P A Curmi; C Noguès; S Lachkar; N Carelle; M P Gonthier; A Sobel; R Lidereau; I Bièche
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

10.  Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis.

Authors:  Katarina Wolf; Irina Mazo; Harry Leung; Katharina Engelke; Ulrich H von Andrian; Elena I Deryugina; Alex Y Strongin; Eva-B Bröcker; Peter Friedl
Journal:  J Cell Biol       Date:  2003-01-13       Impact factor: 10.539

View more
  67 in total

1.  The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53.

Authors:  Bruce K Carney; Victoria Caruso Silva; Lynne Cassimeris
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-29

2.  STAT3-stathmin interactions control microtubule dynamics in migrating T-cells.

Authors:  Navin K Verma; Jennifer Dourlat; Anthony M Davies; Aideen Long; Wang-Qing Liu; Christiane Garbay; Dermot Kelleher; Yuri Volkov
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

Review 3.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

4.  Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.

Authors:  Jennifer Yinuo Cao; Sheila Mansouri; Lori Frappier
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 5.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

6.  Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling.

Authors:  Simon Schimmack; Andrew Taylor; Ben Lawrence; Hubertus Schmitz-Winnenthal; Lars Fischer; Markus W Büchler; Irvin M Modlin; Mark Kidd; Laura H Tang
Journal:  Tumour Biol       Date:  2014-09-30

7.  Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma.

Authors:  Han-Ping Hsu; Chien-Feng Li; Sung-Wei Lee; Wen-Ren Wu; Tzu-Ju Chen; Kwang-Yu Chang; Shih-Shin Liang; Chia-Jung Tsai; Yow-Ling Shiue
Journal:  Tumour Biol       Date:  2013-11-12

8.  Phospho-Network Analysis Identifies and Quantifies Hepatitis C Virus (HCV)-induced Hepatocellular Carcinoma (HCC) Proteins Regulating Viral-mediated Tumor Growth.

Authors:  Nu T Lu; Natalie M Liu; James Q Vu; Darshil Patel; Whitaker Cohn; Joe Capri; Mary Ziegler; Nikita Patel; Angela Tramontano; Roger Williams; Julian Whitelegge; Samuel W French
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

9.  Gene expression profiles in mouse embryo fibroblasts lacking stathmin, a microtubule regulatory protein, reveal changes in the expression of genes contributing to cell motility.

Authors:  Danielle N Ringhoff; Lynne Cassimeris
Journal:  BMC Genomics       Date:  2009-07-30       Impact factor: 3.969

Review 10.  The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells.

Authors:  K Panková; D Rösel; M Novotný; Jan Brábek
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.